Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amylin, Lilly, Alkermes Shares Slump as FDA Rejects Bydureon Diabetes Drug
Amylin, Lilly, Alkermes Shares Slump as FDA Rejects Bydureon Diabetes Drug
Amylin, Lilly, Alkermes Shares Slump as FDA Rejects Bydureon Diabetes Drug
Submitted by
admin
on October 20, 2010 - 10:46am
Source:
Bloomberg
News Tags:
Amylin
Eli Lilly
Alkermes
FDA
Bydureon
diabetes
Headline:
Amylin, Lilly, Alkermes Shares Slump as FDA Rejects Bydureon Diabetes Drug
Do Not Allow Advertisers to Use My Personal information
